Een abonnement op JoVE is vereist om deze inhoud te bekijken. Log in of start vandaag met uw gratis proefperiode.

Methodenartikel

Generation of Spheroids from Human Pluripotent Stem Cells

848 weergaven

8 juli 2025

In dit artikel

Samenvatting

Source: Shaker, M. R., et al. Robust and Highly Reproducible Generation of Cortical Brain Organoids for Modelling Brain Neuronal Senescence In Vitro. J. Vis. Exp. (2022).

This video demonstrates the transformation of human pluripotent stem cells (hPSCs) into spherical brain organoids. By using specific inhibitors, the hPSCs are guided to differentiate towards a neuronal lineage, forming neuroectodermal colonies. Special growth factors are then introduced, which encourage the self-organization and proliferation of the colonies, ultimately leading to the formation of spherical brain organoids.

Protocol

1. Cortical brain organoid generation (Figure 1)

NOTE: All the steps in this section of the protocol will occur in a Class 2 biosafety hood unless stated otherwise.

  1. Induction of 2D neuroectodermal colonies from human pluripotent stem cells (hPSCs) 2D culture (Days -1 to 3)
    1. Before induction, plate the hPSC colonies on a human embryonic stem cell (hESC) qualified basement membrane matrix in a 6-well plate at 20%-30% density. Achieve this density by passaging hPSC colonies from one well of a 6-well plate at 60% confluency into three wells of a 6-well plate.
    2. For basement membrane matrix coating, dilute the basement membrane matrix at a ratio of 1:50 in a plain basal medium. Evenly deposit 1 mL/well of a 6-well plate, incubate for 1 hour at room temperature (RT), and then aspirate.
    3. Maintain hPSC colonies for 1 day in 2 mL of a serum-free cell culture medium prior to differentiation.
    4. On the day of hPSC differentiation, inspect the hPSC colonies using brightfield microscopy at 4x to 10x magnification to ensure healthy colonies with no detectable differentiation.
      NOTE: Healthy hPSCs will form tight edge colonies with cells that have a large nucleus, very small cytoplasm, and prominent nucleoli. Differentiated iPSC colonies will exhibit clear morphological differences to that of the described hPSC colonies above, particularly around the outer edges of the colonies or at the center.
    5. Add reagents listed in Table 1 to make up the N2 medium required for differentiation. Bring this medium to RT before use.
    6. Once at RT, aspirate the serum-free cell culture medium from each well of the 6-well plate and replace it with 2 mL of N2 medium gently added with a 5 mL serological pipette.
    7. Add the dual Suppressor of Mothers against Decapentaplegic (SMAD) inhibitors, SB-431542 (10 µM) and LDN 193189 (100 nM).
      NOTE: The SMAD inhibitors can be added to the N2 medium after the medium has been placed in each well or to the required amount of N2 medium prior to replacing the serum-free cell culture medium. Inhibitors can be evenly incorporated into the medium by gently swirling the plate or inverting the tube containing the medium and inhibitors 3-4 times.
    8. Add fresh N2 media supplemented with SB-431542 (10 µM) and LDN 193189 (100 nM) daily to each well for the next 2 days.
      NOTE: Fresh N2 medium is added to reduce the prolonged exposure of cells to the Dimethyl sulfoxide (DMSO) that is used to dissolve SB-431542 and LDN 193189 compounds and prevent cytotoxicity.
  2. Generation of 3D neuroectodermal spheroids from induced 2D neuroectodermal colonies (Days 3 to 7)
    1. Lift the induced neuroectodermal colonies using dispase following steps 1.2.2-1.2.8.
    2. First, remove 2 mL of N2 medium from the 6-well plate, and wash 1x with HBSS to ensure that all of the N2 medium is removed.
      NOTE: N2 medium can interfere with the enzyme activity of dispase, preventing adequate detachment of neuroectodermal colonies from the well.
    3. Add 1 mL of 2.4 unit/mL dispase to each colony-containing well.
    4. Incubate the well for 20-25 min (maximum 30 min) at 37 °C. Check for colony detachment regularly.
      NOTE: Small colonies may detach within 20 minutes. Any colonies that remain stuck down after 30 min should be ignored.
    5. After incubation, add 1 mL of N2 medium to the well to stop the activity of the dispase enzyme and transfer the colonies into a 15 mL tube using a wide-bore P1000 pipette tip or a modified P1000 pipette tip cut with sterile scissors (making it a wide-bore P1000 tip).
    6. Allow the colony clumps to sink to the bottom of the tube with gravity.
      NOTE: This process will take approximately 1 minute.
    7. Once the clumps have sunk, carefully remove the supernatant with a standard P1000 pipette tip and replace it with 1 mL of fresh N2 medium. Repeat this washing step three times to ensure complete removal of dispase.
      NOTE: Any remaining dispase will prevent a uniform formation of neuroectodermal spheroids and induce cell death.
    8. After washing, resuspend the cell clumps in 3 mL of N2 medium, transfer to one well of a 6-well plate, and add 40 ng/mL of basic fibroblast growth factor (bFGF).
      NOTE: If a high number of neuroectodermal colonies were detached, these colonies could be plated across two or more wells of a 6-well plate to prevent spheroids fusion. 24 h after dispase detachment of the colonies, check whether the spheroids have formed.
    9. Maintain the spheroids in the same media for the next 3-4 days but add fresh bFGF (40 ng/mL) to each well daily to promote neuroectodermal cell proliferation, self-organizing, and induce and expand neuroepithelia.
      NOTE: If spheroids have been plated at a higher density, the media is likely to turn yellow and require replacing every 2 days with fresh bFGF (40 ng/mL). However, this is not recommended, and instead, a lower number of spheroids should be maintained in each well to avoid this issue. Spheroids can be embedded in the basement membrane matrix after 3 days if neuroepithelia are evident. If neuroepithelia are not evident or do not look strong, then maintain the spheroids for another day and check again.

Table 1: N2 Medium. The table lists the reagents required to prepare the N2 medium.

Media componentsConcentration
DMEM Nutrient mix F12 10x 500 mL (DMEM/F-12)
N2 Supplement 5 mL (100x)Supplmented at 1%
B 27 Supplement 10 mLSupplemented at 2%
MEM Non-Essential Amino Acids Solution (100x)Supplemented at 1%
Penicillin-Streptomycin (10,000 U/mL)Supplemented at 1%
2-Mercaptoethanol 50 mL(1000x )Supplemented at 0.1%

Toegang beperkt. Log in of start een proefperiode om deze inhoud te bekijken.

Resultaten

iPSC differentiation diagram: colony induction, spheroid formation, embedding in basement membrane.
Figure 1: Schematic diagram for generating reproducible cortical brain organoids. Schematic workflow of the experimental procedure for the generation of cortical brain organoids from hPSCs maintained in the feeder-free medium. The workflow provides an ov...

Toegang beperkt. Log in of start een proefperiode om deze inhoud te bekijken.

Openbaarmakingen

No conflicts of interest declared.

Materialen

Lijst van materialen gebruikt in dit artikel
NaamBedrijfCatalogusnummerOpmerkingen
16% Formaldehyde (W/V) Methanol-freeThermo Fisher Scientific289084% of PFA are diluted in 1x PBS
2-Mercaptoethanol 50 mL(1000x)Life Technologies Australia (TFS)21985023Used in NM and DM media
B 27 Supplement 10 mLLife Technologies Australia (TFS)17504044Used in NM and DM media
CKX53 microscope with SC50 cameraOlympus
Corning Costar 6 well cell culture platesSigma Aldrich Pty LtdCLS3516-50EA
Dispase II powderThermo Fisher Scientific17105041Powder is dissolve in HBSS, filtered through 0.22 µm filter, aliquote at 10 mL and store at -20 °C
DMEM Nutrient Mix F12 10x 500 mL (DMEM/F-12)Thermofisher11320082Used in NM and DM media
DMSO Dimethyl SulfoxideSigma Aldrich Pty LtdD2650-100ML
Dulbecco's Phosphate Buffered SalineSigma Aldrich Pty LtdD1408-500ML
Falcon Matrigel hESC-qualified MatrixIn Vitro Technologies Pty LtdFAL354277Make aliquotes of 100 µL and stored at -20 °C
GlutaMAX Supplement 100xThermo Fisher Scientific35050061Used in NM and DM media
Hanks Balanced Salt SolutionSigma Aldrich Pty LtdH8264
Human induced pluripotent stem cells (EU79)In-house reporogrammed from skin fibroblast
Human induced pluripotent stem cells (G22)Genea BiocellsObtained from Genea Biocells (San Diego, United States)
Human induced pluripotent stem cells (WTC)Gift from Professor Bruce Conklin
InSolution TGF-Β RI Kinase Inhibitor VI, SB431542MerckUS1616464-5MG
Insulin Solution Human RecombinantSigma Aldrich Pty LtdI9278Used in NM and DM media
LDN193189 DihydrochlorideSigma Aldrich Pty LtdSML0559-5MGUsed during differentiation
MEM Non-Essential Amino Acids Solution (100x)Thermo Fisher Scientific11140050Used in NM and DM media
mTeSR PlusSTEMCELL TECHNOLOGIES100-0276Used to maintain hiPSC colonies prior to differentiation with NM media
N2 Supplement 5 mL (100x)Life Technologies Australia Pty Ltd17502048Used in NM and DM media
Penicillin-Streptomycin (10,000 U/mL)Thermo Fisher Scientific15140122Used in NM and DM media
Recombinant Human FGF basicR&D Systems233-FB-01MAliquots are made at 20 µg/mL and stored at -20 °C
SB431542Tocris1614Used during differentiation
Ultra-Low attachment multiwell plates, 24-well plate, polystyreneSigma Aldrich Pty LtdCLS3473-24EA

Trefwoorden

Neuroectodermale koloniessfero dvormingduale SMAD remmerskolonie losmakingDispase behandelingbFGF suppletieN2 mediumkolonie overdrachtzelforganisatie